✦ LIBER ✦

Cost–Utility Analysis of Paclitaxel in Combination with Cisplatin for Patients with Advanced Ovarian Cancer

✍ Scribed by Ana Ortega; George Dranitsaris; Jeremy Sturgeon; Heather Sutherland; Amit Oza

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, epirubicin and paclitaxel com

✍ C. Papadimitriou; D. Lazaris; A. Rodolakis; C. Kiamouris; G.M. Gourgoulis; E. Ga 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Paclitaxel, cisplatin and epirubicin (PC

✍ C. Papadimitriou; A. Anagnostopoulos; Z. Voulgaris; G. Vlahos; E. Kioses; T. Akr 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Efficacy of paclitaxel in combination wi

✍ Topuz, E.; Aydiner, A.; Eralp, Y.; Saip, P.; Tas, F.; Salihoglu, Y.; Berkman, S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Combination therapy with epirubicin, pac

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Phase II study of paclitaxel (taxol, gem

✍ Van den Bosch, J.; Hoekman, K.; Verheyen, R.H.M.; Pinedo, H.M. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Peripheral neuropathy due to therapy wit

✍ C.C.P. Verstappen; T.J. Postma; K. Hoekman; J.J. Heimans 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 57 KB